Aktienanalyse zu ICU Medical Inc (ICUI)ICUIICU Medical Inc

ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume intravenous (IV) pumps and safety software, dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, sharps safety products, and sterile IV solutions. Its product offerings also include Consumables, Infusion Systems and Vital Care. Its consumables business unit includes infusion therapy, oncology, vascular access, and tracheostomy products. Its infusion systems offer a portfolio of infusion pumps, software, and professional services. Its vital care business unit includes hemodynamic monitoring, general anesthesia and respiratory, temperature management solutions and regional anesthesia/pain management products. Its infusion therapy products include infusion sets, extension sets, needle-free connectors, and disinfection caps. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).

ICU Medical Inc is a good buy right now due to its strong financial performance and positive market sentiment. The current price is $160.32, and the company has shown a gross margin improvement to 42.61% in Q2 2026, indicating operational efficiency. Additionally, the forward P/E ratio is 16.95, suggesting the stock is reasonably valued relative to its earnings potential. The main risk is the recent insider selling, with the CFO selling 6,381 shares at an average price of $175, which could raise concerns among investors, but this was part of a pre-scheduled trading plan.

5 analysts cover ICUI: 2 rate it Buy, 3 Hold and 0 Sell. The average price target is 173.50.